Busy M&A activity sets tone as biopharma earnings season kicks off

July 13, 2026 10:38 AM EDT DealsPharma Bio­phar­ma's 'ex­tra­or­di­nary year' for M&A sets tone as earn­ings sea­son be­gins Max Gelman Senior Editor With the first half of 2026 of­fi­cial­ly in the books and an­oth­er earn­ings sea­son about to be­gin, a key ques­tion hangs over the bio­phar­ma in­dus­try: … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER